Issue Price
₹135
Per Share
GMP
NIL
Grey Market
Est. Listing
₹135
Expected Price
Min. Application
₹270,000
2 lots × 1000 shares
Incorporated in 2003, Infinium Pharmachem Limited manufactures & supplies Iodine Derivatives, APIs, and Iodination reaction-based bulk drugs.The company offers R & D services and commercial scale manufacturing and packaging for Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals & other chemical industries.Infinium Pharmachem's manufacturing plant is located in Gujarat - INDIA, which spans across 4100 Sq. Mtr. Plot area. The facility is FDA certified & GMP compliant with capabilities of producing complex Iodine Derivatives. The company serves to over 15+ countries across the globe and has over 200+ Iodine Derivatives and 7+ APIs.
Infinium Pharmachem Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 94,000 | — | ₹1.27 Cr | — |
| TOTAL | 1,875,000 | 100.00% | ₹25.31 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹135,000 |
| Retail (Max) | 13 | 13,000 | ₹1,755,000 |
| sNII (Min) | 14 | 14,000 | ₹1,890,000 |
| bNII (Min) | 68 | 68,000 | ₹9,180,000 |
| Particulars | 30-Sep-22 | 31-Mar-22 | 31-Mar-21 |
|---|---|---|---|
| Revenue from Operations | 7985.39 | 10005.25 | 7115.37 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 551.01 | 610.64 | 272.48 |
| Net Worth | 1855.77 | 1310.22 | 702.32 |
| Total Assets | 7075.71 | 5899.95 | 3418.27 |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | 1614.71 | 1385.01 | 579.47 |